Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Genomic Imprinting Testing for Detection and Surveillance of Bladder Cancer Patients

NCT03563443 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT03563443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03563443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Genomic Imprinting Testing for Detection and Surveillance of Bladder Cancer Patients
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2017
Completion date
December 15, 2019
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, diagnoses disease, urine marking